Loading...
A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
Ovarian cancer is the second most important pelvic gynaecologic malignancy and nowadays still kills 80% of patients. New treatment options are mandatory. Although it has been shown that ovarian cancer is an immunogenic tumor, the possibility of developing immunotherapy has been neglected for a long...
Saved in:
| Published in: | Facts Views Vis Obgyn |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Universa Press
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4402447/ https://ncbi.nlm.nih.gov/pubmed/25897374 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|